Synapse - Boglarka Gyurkocza

Results (138)

Geriatric assessment and outcomes of allogeneic hematopoietic cell transplantation in older patients

Meeting Abstract

Dahi, P. B.; Shahrokni, A.; Flynn, J.; Devlin, S. M.; Chinapen, S. A.; Ayala, J.; Brown, S.; Bugen, S.; Cho, C.; Gyurkocza, B.; more...
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

A randomized phase 3 study of allogeneic HCT with Iomab-B versus conventional care in older patients with active, relapsed/refractory AML: Pivotal SIERRA trial results

Meeting Abstract

Giralt, S.; Gyurkocza, B.; Seropian, S.; Choe, H.; Litzow, M.; Abboud, C.; Koshy, N.; Stiff, P.; Tomlinson, B.; Abhyankar, S.; more...
Bone Marrow Transplantation (2023)

Fulltext@MSK | Save

The Simplified Comorbidity Index predicts non-relapse mortality in reduced-intensity conditioning allogeneic haematopoietic cell transplantation

Journal Article

Elias, S.; Brown, S.; Devlin, S. M.; Barker, J. N.; Cho, C.; Chung, D. J.; Dahi, P. B.; Giralt, S.; Gyurkocza, B.; Jakubowski, A. A.; more...
British Journal of Haematology (2023)

Fulltext@MSK | Save

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with acute leukemia

Journal Article

Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
American Journal of Hematology (2023)

Fulltext@MSK | Save

The randomized Phase III SIERRA (Study of Iomab-B in Elderly relapsed or refractory AML) trial: Successful allogeneic hematopoietic stem cell transplantation using treatment with Iomab-B-led regimen for patients with active, relapsed or refractory AML with failed targeted therapies

Meeting Abstract

Nath, R.; Seropian, S.; Choe, H.; Litzow, M. R.; Abboud, C.; Koshy, N.; Stiff, P. J.; Tomlinson, B.; Abhyankar, S.; Foran, J. M.; more...
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Should patients with AML and active disease be transplanted?

Meeting Abstract

Gyurkocza, B.
Clinical Lymphoma, Myeloma and Leukemia (2023)

Fulltext@MSK | Save

Association between busulfan exposure and survival in patients undergoing a CD34(+) selected stem cell transplantation

Journal Article

Tamari, R.; Scordo, M.; Kunvarjee, B. M.; Proli, A.; Lin, A.; Flynn, J.; Cho, C.; Devlin, S.; Klein, E.; Boulad, F.; more...
Blood Advances (2023)

Fulltext@MSK | Save

Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia

Journal Article

Fingrut, W. B.; Gyurkocza, B.; Flynn, J.; Davis, E.; Devlin, S.; Scaradavou, A.; Chinapen, S.; Quach, S.; Cho, C.; Giralt, S. A.; more...
Blood Advances (2023)

Fulltext@MSK | Save

High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients

Journal Article

Nguyen, C. L.; Markey, K. A.; Miltiadous, O.; Dai, A.; Waters, N.; Sadeghi, K.; Fei, T.; Shouval, R.; Taylor, B. P.; Liao, C.; more...
Cell (2023)

Fulltext@MSK | Save

Molecular predictors of immunophenotypic measurable residual disease clearance in acute myeloid leukemia

Journal Article

Stahl, M.; Derkach, A.; Farnoud, N.; Bewersdorf, J. P.; Robinson, T.; Famulare, C.; Cho, C.; Devlin, S.; Menghrajani, K.; Patel, M. A.; more...
American Journal of Hematology (2023)

Fulltext@MSK | Save